在过早心室收缩的切除过程中,QRS复合物的缩小
Helge Haarmann1, Nibras Soubh1, Eva Rasenack1
1Clinic for Cardiology and Pneumology, Heart Center, University Medical Center Göttingen, Germany.
在过早心室收缩的废除过程中,观察到QRS复合体的缩小,该复合体的患者已经离开了捆绑分支块. 这一发现对于理解心脏电生理学在剥离过程中的重要.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 过早的心室收缩 (PVCs) 可能很难切除,特别是在患有先前传导异常的患者中.
- 左捆分支阻塞 (LBBB) 影响心室脱极化模式,可能使电生理学评估复杂化.
- 射频除是症状PVC的常见治疗方法.
研究的目的:
- 在LBBB.患者的PVC剥离过程中报告一个不寻常的电生理学发现.
- 描述在废除过程中观察到QRS复杂收窄的情况.
主要方法:
- 一个病人的病例报告为PVC进行了导管切除.
- 在手术过程中进行心内电图记录和12导电图监测.
- 分析QRS复杂形态变化与除能量交付相关的分析.
主要成果:
- 在切除PVC时观察到QRS复合物的显著缩小.
- 这种缩小发生在除能量的应用期间.
- 底层的节奏是左捆的分支块.
结论:
- 在患有LBBB的患者中,PVC切除过程中,QRS复合体狭窄可能是一个急性,短暂的发现.
- 这种现象可能反映在导管操纵或能量输送期间心室导电发生变化.
- 需要进一步的研究,以了解这一观察的机制和临床影响.
更多相关视频
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
相关概念视频
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Correlation between ECG and Cardiac Cycle
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Electrophysiology of Normal Cardiac Rhythm
